New! ProFound AI for DBT v3.0
The Clear Leader in Breast AI.
Learn More
FDA Cleared, CE Mark
Contact Us for Additional Information About ProFound AI 3.0
<
>
Who is iCAD?
iCAD is a global medical technology leader providing innovative cancer detection and therapy solutions. We work passionately to provide precise, powerful healthcare solutions expertly engineered to optimize operational efficiency, clinician confidence and patient outcomes.
ADVANCED CANCER DETECTION SOLUTIONSInnovative Cancer Therapy solutions
ProFound Recovery
Discover powerful AI solutions to overcome imaging challenges presented by the COVID-19 pandemic
LEARN MORE
Recent News
July 22, 2021
iCAD to Report Second Quarter 2021 Financial Results on Thursday, August 5
June 14, 2021
iCAD’s ProFound AI for Digital Breast Tomosynthesis Version 3.0 Receives CE Mark Approval
June 8, 2021
iCAD Signs Global Distribution Agreement with Sectra
May 17, 2021
iCAD to Participate in Upcoming Virtual Investor Conferences
» View All News »
CONNECT
© iCAD Inc. All rights reserved. iCAD, the iCAD logo, PowerLook, ProFound AI, ProFound, Xoft, the Xoft logo, Axxent, Electronic Brachytherapy System and eBx are trademarks of iCAD, Inc. Reproduction of any of the material contained herein in any format or media without the express written permission of iCAD, Inc. is prohibited.